Advisors Asset Management, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Advisors Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$23.68 - $38.51 $47 - $77	-2 Reduced 0.4%	500 $12,000
Q3 2022 Nov 08, 2022	SELL	$29.63 - $48.31 $592 - $966	-20 Reduced 2.31%	845 $28,000
Q2 2022 Aug 08, 2022	BUY	$27.79 - $50.61 $4,029 - $7,338	145 Added 20.14%	865 $30,000
Q1 2022 May 17, 2022	BUY	$39.62 - $69.97 $13,867 - $24,489	350 Added 94.59%	720 $33,000
Q4 2021 Feb 15, 2022	BUY	$58.09 - $82.51 $3,775 - $5,363	65 Added 21.31%	370 $25,000
Q3 2021 Nov 12, 2021	BUY	$58.38 - $84.96 $17,805 - $25,912	305 New	305 $19,000

294

90.8M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.01B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisors Asset Management, Inc. with notifications on news.